Brühl AB

Universität Basel, Basel, Schweiz.

3 papers · ORCID

ArticleKetamine

[Recognising and treating depression - a practical overview of current treatment algorithms and evidence-based recommendations].

Brühl AB, Kawohl W

Europe PMC2026
ArticleKetamine

Real-world comparison of intranasal racemic ketamine and esketamine in treatment-resistant depression: A retrospective observational study.

Sarlon J, Thomi D, Brühl AB +2

Europe PMC2026
ArticleKetamine

Listening to music during intranasal (es)ketamine therapy in patients with treatment-resistant depression correlates with better tolerability and reduced anxiety.

Hauser J, Sarlon J, Liwinski T +2

Europe PMC2024